Back

Non-fatal major cardiovascular events associated with androgen receptor pathway inhibitors in prostate cancer: systematic review and network meta-analysis

19 June 2026 (10:45 - 11:30)
Organised by: Logo
Congress Presentation Part of: From exposure to events: cardiovascular risk in cancer care Diagnosis and Management of Cardiovascular Disease in Patients with Cancer Delegates Premium Access ESC Cardio-Oncology 2026 Council of Cardio-Oncology

About the speaker

Photo
Doctor Charles Dolladille

University Hospital of Caen, Caen (France)

4 More presentations in this session

Presentation thumbnail
Pembrolizumab plus anthracyclines in triple-negative breast cancer: prospective evaluation of early cardiac safety
Miss A. Besnard (Angers, FR)
Abstract Slides
Presentation thumbnail
Baseline cardiovascular assessment and incidence of major adverse cardiovascular events during immune checkpoint inhibitor therapy in a hungarian population
Doctor Z. Drobni (Budapest, HU)
Abstract Slides
Presentation thumbnail
The myocardial effects of proton vs. photon radiotherapy in left-sided breast cancer patients: a cardiac MRI study
Doctor V. Juhasz (Boston, US)
Abstract Slides
Presentation thumbnail
X-ray irradiation of the apex of the heart affects cardiac function by modulating the sympathetic nervous system and calcium transients
Doctor V. Monceau (Fontenay-aux-Roses, FR)
Abstract Slides

Access the full session

Session thumbnail
From exposure to events: cardiovascular risk in cancer care

The Event

Event poster

ESC Cardio-Oncology 2026

19 June 2026 10:45 CET

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources